
iCardiac
AcquiredClario generates the richest clinical evidence
Philadelphia, United States · $4.0M raised
- Headquarters
- Philadelphia, Pennsylvania
- Employees
- 1001–5000
- Business Model
- B2B
- Website
- ert.com
- Total Funding
- $4.0M
- Last Round
- $4.0M Venture RoundMar 2014
- Rounds
- 3
About
Advanced cardiac safety analysis technologies using ECG-based tools for clinical trials; acquired by ERT.
Summary
iCardiac is a Biotech company based in Philadelphia, United States. It has raised $4.0M in total across 3 rounds, most recently a $4.0M Venture Round round in Mar 2014. Investors include Shiv Chaudhary, ADvantage and Topmark Partners.
Tech & App Stack
7 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Dec 2017
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company

Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
